AIDS research, with $ 8.
As the HIV / AIDS is the world lay claim to more than 25 million lives and infected more than 39 million U.S. dollars, researchers continue to both a cure and better treatments for searching those who suffer with this disease. Now, the leading cause of death worldwide among 15 to 59, AIDS is a very strong opponent with the powerful ability to evolve quickly. This trend greatly complicates the treatment, reducing the effectiveness of drugs and requires the continuous development of new therapies.University of Massachusetts Medical School Professor of Biochemistry, Medical Center, Stanford University Professor Robert Shafer, MD, University of North Carolina School of Medicine professor Ronald Swanstrom, Ph.D., and the Massachusetts Institute of Technology Professor Bruce Tidor,
PhD. M. Rana, in addition to his work in synthetic organic chemistry RNAis therapeutic screens and high-flow chemical focuses on HIV-related targets. Dr. Shafer is a physician who specializes in drug resistance to infectious diseases and is the developer of the widely used databases from one patient to the sequences of the HIV protease and reverse transcriptase.Dr. Swanstrom uses molecular virology and biochemistry of retroviruses in general and the mechanisms of resistance to HIV drugs in particular. Dr. Tidor develops computational methods for drug design using the inverse of the optimal charge interactions and complementarity within a ligand binding pocket.About the University of Massachusetts Medical School, University of Massachusetts Medical School, one of the most
dynamic academic in the country, has built a reputation as an institution of world-class research, regularly producing significant advances in the basic and clinical research. The Medical School attracts more than $ 176 million in research funding annually, 80 percent comes from federal funding sources. The work of UMMS researcher Craig Mello, Ph.D., a researcher at the prestigious Howard Hughes Medical Institute (HHMI), Pages: [1] 2